Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin for Sedation and Quality of Life in Critically Ill Patients
NCT00470821Phase 4Completed
- Sponsor
- University of Milan
- Start
- May 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sleep disorders and delirium comparing Placebo with Melatonin (2 arms). Primary endpoint: Overall sedatives daily doses. Started May 2007; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disordersdelirium
Beyond the preview
Go deeper on NCT00470821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470821.